Accuray Incorporated Reports $21.7M Loss, Stock Drops
Update: 2025-11-05
Description
Despite generating revenue, Accuray Incorporated, a radiation oncology firm, reported a substantial loss of $21.7 million in Q1, leading to an 18-cent loss per share. The company's stock value has also declined, dropping from $1.92 to $1.45 over the past year, reflecting the challenges in the competitive healthcare technology market.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
